US Stock MarketDetailed Quotes

ACXP Acurx Pharmaceuticals

Watchlist
  • 2.110
  • -0.030-1.40%
Close Aug 2 16:00 ET
  • 2.140
  • +0.030+1.42%
Post 20:01 ET
33.43MMarket Cap-1788P/E (TTM)

Acurx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
24.27%8.92M
-17.97%7.47M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-29.69%9.11M
-26.64%10.61M
-46.82%9.09M
-Cash and cash equivalents
24.27%8.92M
-17.97%7.47M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-29.69%9.11M
-26.64%10.61M
-46.82%9.09M
Receivables
--0
--129.16K
--129.16K
----
----
----
--0
--0
----
----
-Other receivables
----
--129.16K
--129.16K
----
----
----
----
----
----
----
Prepaid assets
-9.05%187.91K
-60.08%105.78K
-60.08%105.78K
-68.70%105.72K
-23.03%89.94K
-13.72%206.6K
-10.28%264.96K
-10.28%264.96K
-36.33%337.81K
-66.08%116.86K
Total current assets
23.34%9.11M
-17.78%7.71M
-17.78%7.71M
-34.60%7.16M
0.29%9.24M
-34.77%7.39M
-29.25%9.38M
-29.25%9.38M
-26.98%10.95M
-47.20%9.21M
Non current assets
Non current deferred assets
----
----
----
----
----
----
----
----
----
--50.25K
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--50.25K
Total assets
23.34%9.11M
-17.78%7.71M
-17.78%7.71M
-34.60%7.16M
-0.25%9.24M
-34.77%7.39M
-29.25%9.38M
-29.25%9.38M
-26.98%10.95M
-46.91%9.26M
Liabilities
Current liabilities
Payables
-50.02%9.2K
-87.11%3.81K
-87.11%3.81K
97.34%11.72K
123.44%12.88K
189.69%18.41K
-53.39%29.54K
-53.39%29.54K
-51.08%5.94K
-94.06%5.76K
-Other payable
-50.02%9.2K
-87.11%3.81K
-87.11%3.81K
97.34%11.72K
123.44%12.88K
189.69%18.41K
-53.39%29.54K
-53.39%29.54K
-51.08%5.94K
-94.06%5.76K
Current accrued expenses
51.32%3.08M
55.94%2.32M
55.94%2.32M
241.66%3M
572.05%2.97M
233.06%2.04M
447.13%1.49M
447.13%1.49M
96.24%879.49K
-75.46%442.03K
Current liabilities
49.96%3.11M
47.57%3.04M
47.57%3.04M
172.69%3.22M
537.17%3.02M
227.63%2.07M
144.30%2.06M
144.30%2.06M
65.92%1.18M
-75.30%473.88K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
49.96%3.11M
47.57%3.04M
47.57%3.04M
172.69%3.22M
537.17%3.02M
227.63%2.07M
144.30%2.06M
144.30%2.06M
65.92%1.18M
-75.30%473.88K
Shareholders'equity
Share capital
35.00%15.76K
24.42%14.47K
24.42%14.47K
12.18%13.01K
26.72%13.01K
13.73%11.67K
13.82%11.63K
13.82%11.63K
14.48%11.59K
3.50%10.26K
-common stock
35.00%15.76K
24.42%14.47K
24.42%14.47K
12.18%13.01K
26.72%13.01K
13.73%11.67K
13.82%11.63K
13.82%11.63K
14.48%11.59K
3.50%10.26K
Retained earnings
-38.64%-57.6M
-37.73%-53.22M
-37.73%-53.22M
---48.1M
---44.99M
---41.54M
---38.64M
---38.64M
----
----
Paid-in capital
35.73%63.58M
25.96%57.87M
25.96%57.87M
15.27%52.03M
26.05%51.19M
17.41%46.84M
17.96%45.94M
17.96%45.94M
18.18%45.13M
16.74%40.61M
Gains losses not affecting retained earnings
----
----
----
----
----
----
----
----
-47.90%-35.38M
-65.15%-31.84M
Total stockholders'equity
12.94%6M
-36.20%4.67M
-36.20%4.67M
-59.70%3.93M
-29.24%6.22M
-50.31%5.31M
-41.06%7.32M
-41.06%7.32M
-31.62%9.76M
-43.40%8.79M
Total equity
12.94%6M
-36.20%4.67M
-36.20%4.67M
-59.70%3.93M
-29.24%6.22M
-50.31%5.31M
-41.06%7.32M
-41.06%7.32M
-31.62%9.76M
-43.40%8.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 24.27%8.92M-17.97%7.47M-17.97%7.47M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M-29.69%9.11M-26.64%10.61M-46.82%9.09M
-Cash and cash equivalents 24.27%8.92M-17.97%7.47M-17.97%7.47M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M-29.69%9.11M-26.64%10.61M-46.82%9.09M
Receivables --0--129.16K--129.16K--------------0--0--------
-Other receivables ------129.16K--129.16K----------------------------
Prepaid assets -9.05%187.91K-60.08%105.78K-60.08%105.78K-68.70%105.72K-23.03%89.94K-13.72%206.6K-10.28%264.96K-10.28%264.96K-36.33%337.81K-66.08%116.86K
Total current assets 23.34%9.11M-17.78%7.71M-17.78%7.71M-34.60%7.16M0.29%9.24M-34.77%7.39M-29.25%9.38M-29.25%9.38M-26.98%10.95M-47.20%9.21M
Non current assets
Non current deferred assets --------------------------------------50.25K
Total non current assets --0--0--0--0--0--0--0--0--0--50.25K
Total assets 23.34%9.11M-17.78%7.71M-17.78%7.71M-34.60%7.16M-0.25%9.24M-34.77%7.39M-29.25%9.38M-29.25%9.38M-26.98%10.95M-46.91%9.26M
Liabilities
Current liabilities
Payables -50.02%9.2K-87.11%3.81K-87.11%3.81K97.34%11.72K123.44%12.88K189.69%18.41K-53.39%29.54K-53.39%29.54K-51.08%5.94K-94.06%5.76K
-Other payable -50.02%9.2K-87.11%3.81K-87.11%3.81K97.34%11.72K123.44%12.88K189.69%18.41K-53.39%29.54K-53.39%29.54K-51.08%5.94K-94.06%5.76K
Current accrued expenses 51.32%3.08M55.94%2.32M55.94%2.32M241.66%3M572.05%2.97M233.06%2.04M447.13%1.49M447.13%1.49M96.24%879.49K-75.46%442.03K
Current liabilities 49.96%3.11M47.57%3.04M47.57%3.04M172.69%3.22M537.17%3.02M227.63%2.07M144.30%2.06M144.30%2.06M65.92%1.18M-75.30%473.88K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 49.96%3.11M47.57%3.04M47.57%3.04M172.69%3.22M537.17%3.02M227.63%2.07M144.30%2.06M144.30%2.06M65.92%1.18M-75.30%473.88K
Shareholders'equity
Share capital 35.00%15.76K24.42%14.47K24.42%14.47K12.18%13.01K26.72%13.01K13.73%11.67K13.82%11.63K13.82%11.63K14.48%11.59K3.50%10.26K
-common stock 35.00%15.76K24.42%14.47K24.42%14.47K12.18%13.01K26.72%13.01K13.73%11.67K13.82%11.63K13.82%11.63K14.48%11.59K3.50%10.26K
Retained earnings -38.64%-57.6M-37.73%-53.22M-37.73%-53.22M---48.1M---44.99M---41.54M---38.64M---38.64M--------
Paid-in capital 35.73%63.58M25.96%57.87M25.96%57.87M15.27%52.03M26.05%51.19M17.41%46.84M17.96%45.94M17.96%45.94M18.18%45.13M16.74%40.61M
Gains losses not affecting retained earnings ---------------------------------47.90%-35.38M-65.15%-31.84M
Total stockholders'equity 12.94%6M-36.20%4.67M-36.20%4.67M-59.70%3.93M-29.24%6.22M-50.31%5.31M-41.06%7.32M-41.06%7.32M-31.62%9.76M-43.40%8.79M
Total equity 12.94%6M-36.20%4.67M-36.20%4.67M-59.70%3.93M-29.24%6.22M-50.31%5.31M-41.06%7.32M-41.06%7.32M-31.62%9.76M-43.40%8.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg